source
- Tango’s pancreatic cancer combo shows striking promise at ESMO, building on Revolution Medicines’ earlier successTango presented new data on its pancreatic cancer combination at the opening of the ESMO conference, highlighting a striking level of activity that builds on earlier success reported by Revolution…
- Lycia Therapeutics raises $317.5 million in IPO as Merck halts sac-TMT trialLycia Therapeutics, founded by Nobel laureate Carolyn Bertozzi, priced its initial public offering at about $317.5 million, bringing total proceeds to roughly $318 million. The offering marks the…